Forget This Trump eVTOL Darling: A Diversified Defense Contractor Is the Smarter Long‑Term Holding
Vertical Aerospace is making progress with its VX4 eVTOL aircraft -- but is still years away from co…
fool.com
RDY(RDY)
RDY
Earnings in 9 days · May 12, 2026 · Before open
Signal
Leaning Bullish1↑
PRICE
Prev Close
13.64
Open
13.67
Day Range13.64 – 13.79
13.64
13.79
52W Range12.77 – 16.17
12.77
16.17
28% of range
VOLUME & SIZE
Avg Volume
2.3M
FUNDAMENTALS
P/E Ratio
19.1x
EPS (TTM)
—
Div Yield
0.01%
Beta
0.46
Low vol
Performance
1D
+0.59%5D
-0.94%1M
+3.00%3M
+0.81%6M↑
+3.24%YTD↓
-2.28%1Y
-2.00%Best: 6M (+3.24%)Worst: YTD (-2.28%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +11% YoY · 55% gross marginValuation
FAIR
P/E 19x vs ~20x sectorHealth
STRONG
CR 1.9 · FCF $33.49/shStrong Buy
Key MetricsTTM
Market Cap$1.10T
Revenue TTM$345.83B
Net Income TTM$56.59B
Free Cash Flow$24.26B
Gross Margin55.2%
Net Margin16.4%
Operating Margin19.3%
Return on Equity16.0%
Return on Assets10.1%
Debt / Equity0.21
Current Ratio1.88
EPS TTM$67.96
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
3 strong2 watch1 concern
59/100Liquidity
1.88Watch
Leverage
0.21Strong
Coverage
20.0xStrong
ROE
16.0%Strong
ROIC
11.2%Watch
Cash
$14.7BConcern
ANALYST COVERAGE12 analysts
HOLD
Stock Health
Composite Score
2 of 5 signals bullish
4/10
Technicals
●
✓RSI RangeRSI 53 — Bullish momentum
Volume
●
✗Volume FlowLean Distribution — selling pressure
Fundamentals
●
✗Last EarningsMissed estimates
●
~Analyst ConsensusHold
●
✓LiquidityCurrent Ratio 1.88 — healthy liquidity
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
FinancialsFull statements →
Technicals
Technical SetupMIXED
Technicals →Trend
▼ DowntrendDeath Cross · 50D trails 200D by 1.4%
-0.6% vs SMA 50 · -2.0% vs SMA 200
Momentum
RSI53.4Neutral territory
MACD+0.05Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$16.17+17.9%
EMA 200
$14.04+2.4%
Current
$13.72
EMA 50
$13.66-0.5%
52W Low
$12.77-6.9%
52-Week RangeMid-range
$12.7728th %ile$16.17
Squeeze SetupVolume-based
No Clear SetupVolume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.
20-Day Money Flow
Acc days:1
Dist days:4
Edge:+3 dist
Volume Context
Avg Vol (50D)1.6M
Recent Vol (5D)
1.5M-4%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 25 analysts
Analyst revisions:EPS↑ Revised UpRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2024 | $277.3B $241.3B–$289.0B | — | $64.18 | — | ±26% | High25 |
FY2025 | $321.2B $316.0B–$325.5B | ▲ +15.8% | $67.47 | ▲ +5.1% | ±4% | High18 |
FY2026(current) | $345.2B $342.5B–$348.0B | ▲ +7.5% | $60.17 | ▼ -10.8% | ±6% | High18 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryRDY
Last 8Q
-10.8%avg beat
Beat 3 of 8 quartersMissed 4↓ Estimates falling+13%
Q1'24
-19%
Q2'24
+4%
Q3'24
-81%
Q4'24
+4%
Q2'25
-7%
Q3'25
-1%
Q4'25
—
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →Analysts turning cautious
30d▲ 0▼ 1
90d▲ 0▼ 1
Goldman SachsSell
Apr 23
DOWNGRADE
NomuraNeutral
Dec 19
DOWNGRADE
Financials
Dividends1.21% yield
8 yrs of paymentsAnnual Yield1.21%
Annual Div.$0.0915
Est. Annual / Share$0.09
FrequencyAnnual
Q3'18
Q3'19
Q3'20
Q3'21
Q3'22
Q3'23
Q3'24
Q3'25
Dividend per payment — last 8 periods
INSTITUTIONAL OWNERSHIP
1
Robeco Institutional Asset Management B.V.
17.2M▲2
AUGUSTINE ASSET MANAGEMENT INC
250K▲3
Frank, Rimerman Advisors LLC
174K▲4
Sequoia Financial Advisors, LLC
163K▲5
Assenagon Asset Management S.A.
137K▲6
SIGNATUREFD, LLC
127K▼7
GREENLEAF TRUST
123K▲8
Ethic Inc.
120K▲News & Activity
RDY News
20 articles · 4h ago
Roblox Shares Tumble After the Company Slashed Guidance. Is It Time to Buy the Dip or Stay Away?
fool.com
Sam Altman asked GPT-5.5 to plan its own launch party. Its requests were 'beautiful' but 'strange.
businessinsider.com
How Google made peace with war
businessinsider.com
OPEC+ set to agree third oil output quota hike since Hormuz closure, sources say
reuters.com
LEO: Tax-Free Yield And Measured Duration Exposure
seekingalpha.com
Melco Resorts: Q1 2026 Earnings Confirms Our Bullish Case
seekingalpha.com
Smartee Showcases Clinical Innovations in Mandibular Repositioning and Strengthens European Presence at EAS Congress 2026
prnewswire.com
Is Nvidia's Deal With Oklo a Game Changer?
fool.com
Israel approves plan to buy F-35 and F-15I aircraft from US
reuters.com
EgyptAir Takes Delivery of First Boeing 737 MAX Jet
prnewswire.com
Robinhood's Crypto Revenue Took a Hit. Is the Long-Term Story Still Intact?
fool.com
Goldman Sachs Says the Artificial Intelligence (AI) Software Sell-Off Was Overdone. Here Are the Best Growth Stocks to Buy Now.
fool.com
American Express: The Subscription Moat With A Potential AI Bonus On Top
seekingalpha.com
My Top 2 Industrial Stocks for the Iran War Era
fool.com
Alphabet Is Dropping $190 Billion on AI Infrastructure: 3 Semiconductor Stocks Set to Win Big
fool.com
AI chatbot fraud: the ‘gift card' subcription that may cost you dear
theguardian.com
Tyler Technologies: Encouraging Recovery In Bookings (Rating Upgrade)
seekingalpha.com
Why ServiceNow Stock Fell 16% in April
fool.com
Hamilton Insurance: Rally Has Largely Closed The Valuation Gap (Rating Downgrade)
seekingalpha.com
About
They are an Indian multinational pharmaceutical company located in Hyderabad, Telangana, India. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
G. Prasad
Country
India
Website
Motupalli Venkata RamanaCEO of Global Generics & Member of Management Council
Sanjay SharmaExecutive VP, COO & Member of Management Council
Peers— —(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
RDY◀ | $13.72 | +0.59% | $11.4B | 19.5 | +1661.1% | 1737.0% | 1500 |
| $397.67 | +0.41% | $2.1T | 28.7 | +3296.8% | 4510.0% | 1500 | |
| $91.95 | +0.10% | $316.0B | 14.1 | +318.8% | 1510.7% | 1500 | |
| $131.46 | -0.32% | $305.1B | 22.6 | +586.3% | 1305.9% | 1500 | |
| $184.74 | -1.40% | $286.4B | 27.2 | +862.9% | 1745.9% | 1500 | |
| $146.57 | -0.87% | $279.7B | 21.0 | +597.3% | 2564.4% | 1500 | |
| $88.98 | -1.86% | $251.9B | 14.4 | -591.0% | 668.4% | 1500 | |
| Sector avg | — | -0.48% | — | 21.1 | +961.7% | 2006.0% | 1500 |